Artículos de revistas
Facial Pigmentation Associated With Amiodarone
Registro en:
General Dentistry. , v. 61, n. 4, p. e15 - e17, 2013.
3636771
2-s2.0-84881487626
Autor
Gonzalez-Arriagada W.A.
Silva A.R.S.
Vargas P.A.
De Almeida O.P.
Lopes M.A.
Institución
Resumen
Amiodarone is one of the most commonly used drugs for treatment of cardiac arrhythmia. Several undesirable effects are associated with its long-term use. This report describes the case of a 71-year-old female patient, with a diagnosis of cardiac arrhythmia, who presented with a stigmatizing blue-gray facial pigmentation and altered serum values of thyroid hormones associated with the intake of amiodarone. The patient was referred to her cardiologist. The aim of this report is to increase clinicians' awareness about the potential adverse effects of this drug. 61 4 e15 e17 Smith, W., Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy (2011) Heart Lung Circ, 20 (12), pp. 757-760. , Members of CSANZ Cardiovascular Genetics Working Group Van Herendael, H., Dorian, P., Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia (2010) Vasc Health Risk Manag, 6, pp. 465-472 Harris, L., McKenna, W.J., Rowland, E., Holt, D.W., Storey, G.C., Krikler, D.M., Side effects of long-term amiodarone therapy (1983) Circulation, 67 (1), pp. 45-51 Ioannides, M.A., Moutiris, J.A., Zambartas, C., A case of pseudocyanotic coloring of skin after prolonged use of amiodarone (2003) Int J Cardiol, 90 (2-3), pp. 345-346 Sohns, C., Zabel, M., Current role of amiodarone in antiarrhythmic therapy (2010) [Article in German] Herzschrittmacherther Elektrophysiol, 21 (4), pp. 239-243 Itoh, K., Kato, R., Hotta, N., A case report of myolysis during high-dose amiodarone therapy for uncontrolled ventricular tachycardia (1998) Jpn Circ J, 62 (4), pp. 305-308 Bahadir, S., Apaydin, R., Cobanoilu, U., Amiodarone pigmentation, eye and thyroid alterations (2000) J Eur Acad Dermatol Venereol, 14 (3), pp. 194-195 Raptis, L., Papathanasiou, H., Pappas, G., Akritidis, N., It's all in the face: Amiodarone-induced myxedema and skin pigmentation (2006) Eur J Dermatol, 16 (5), pp. 590-591 Pawar, P.S., Woo, D.A., Extrapyramidal symptoms with concomitant use of amitriptyline and amiodarone in an elderly patient (2010) Am J Geriatr Pharmacother, 8 (6), pp. 595-598 Scully, C., Bagan, J.V., Adverse drug reactions in the orofacial region (2004) Crit Rev Oral Biol Med, 15 (4), pp. 221-239 Wiper, A., Roberts, D.H., Schmitt, M., Amiodarone-induced skin pigmentation: Q-switched laser therapy, an effective treatment option (2007) Heart, 93 (1), p. 15 Enseleit, F., Wyss, C.A., Duru, F., Noll, G., Rischitzka, F., The blue man: Amiodarone-induced skin discoloration (2006) Circulation, 113 (5), pp. e63. , Images in cardiovascular medicine Nikolidakis, S., Kyriakides, Z.S., Barbatis, C., Images in cardiology. Blue-grey cutaneous discolouration secondary to amiodarone treatment (2006) Heart, 92 (4), p. 436 Monk, B., Amiodarone-induced photosensitivity and basal-cell carcinoma (1990) Clin Exp Dermatol, 15 (4), pp. 319-320 Maoz, K.B., Dvash, S., Brenner, S., Brenner, S., Amiodaroneinduced skin pigmentation and multiple basal-cell carcinomas (2009) Int J Dermatol, 48 (12), pp. 1398-1400